Order results by:
| Issue | Title | |
| Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
| D. V. Nebieridze, A. S. Safarian | ||
| "... atherosclerosis. This ACE inhibitor ability is a result of their high vasoprotective effect. It provides new ..." | ||
| Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract similar documents |
| O. P. Shevchenko, А. О. Shevchenko | ||
| "... disease including patients after MI ACE inhibitors reduce mortality, risk of repeated MI as well ..." | ||
| Vol 6, No 1 (2010) | SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT | Abstract similar documents |
| N. A. Jaiani | ||
| "... Рассматриваются обоснования и преимущества применения ингибитора АПФ лизиноприла в практической ..." | ||
| Vol 3, No 2 (2007) | RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION | Abstract similar documents |
| M. M. Batyushin, I. V. Derevyankina, M. Z. Gasanov, O. V. Akopova, K. I. Babiyan, Y. N. Boychenko, N. V. Vasilchenko, T. A. Gabysyan, S. Ch. Gayboryan, I. S. Golovatenko, N. M. Demkova, D. O. Dmitriev, E. V. Kirtava, O. L. Kotyankova, G. V. Ludanova, S. A. Lyashenko, A. E. Malichina, O. I. Poroshenko, A. V. Svechnikova, I. Y. Sidorov, E. V. Solyannikova, I. D. Tascheyan, E. A. Heygetyan, S. E. Evruyan | ||
| "... converting enzyme (ACE) inhibitor, thiazid diuretic (indapamide) and dihydropyridine calcium antagonist ..." | ||
| Vol 5, No 1 (2009) | ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL | Abstract similar documents |
| V. I. Podzolkov, K. K. Osadchy | ||
| "... action and advantages over other ACE inhibitors are presented. ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... Rationale and benefits of the use of the ACE inhibitor lisinopril in the clinical practice ..." | ||
| Vol 4, No 2 (2008) | ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva | ||
| "... Aim. To study effects of ACE inhibitor perindopril on markers of endothelial dysfunction ..." | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..." | ||
| Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina, B. B. Gegenava | ||
| Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| S. N. Tereshchenko, N. A. Dzhaiani | ||
| "... The role of ACE inhibitors in modern pharmacotherapy of patients with chronic heart failure (CHF ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 4, No 3 (2008) | COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..." | ||
| Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
| D. B. Nebieridze, A. S. Safaryan | ||
| "... demonstrate the efficacy of ACE inhibitors in slowing down of disease progression related to atherosclerosis ..." | ||
| Vol 6, No 1 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION | Abstract similar documents |
| S. A. Boitsov, R. M. Linchak | ||
| "... attention is paid to usage of ACE inhibitor and calcium antagonist combination. ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya | ||
| "... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..." | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... The results of the main large controlled trials that had proven effect of ACE inhibitors (ACEi ..." | ||
| Vol 5, No 3 (2009) | FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY | Abstract similar documents |
| O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova | ||
| Vol 1, No 1 (2005) | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES | Abstract similar documents |
| S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin | ||
| "... antihypertensive therapy based on ACE-inhibitor spirapril, the second one (control group) continued their usual ..." | ||
| Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
| I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
| "... (emACE/em eminhibitor/em and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..." | ||
| Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
| D. A. Napalkov, E. N. Golovenko | ||
| "... There is grate interest to emACE/em eminhibitors/em which have cardioprotective and neproprotective effects ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... converting enzyme (emACE/em) eminhibitor/em and dihydropyridine calcium antagonist are considered. Data on the efficacy ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
| "... drugs of emACE/em eminhibitor/em and diuretic, “Noliprel forte” (NF) and “Capozide” (CA), in hypertensive high ..." | ||
| Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... - by 70%, emACE/em eminhibitors/em - by 60% (p0.0001). These medications prescription frequency decreased by 15-20 ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the emACE/em eminhibitors/em, marked ..." | ||
| Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| S. A. Boytsov, I. P. Kolos | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... compared with the group without AF. emACE/em eminhibitors/em (ACEi) were prescribed in 127 cases (27.4%), angiotensin ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... . Results of DREAM trial are discussed. Influence of emACE/em eminhibitor/em, ramipril, on risk of diabetes onset ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... The main trails proven angiotensin converting enzyme (emACE/em) eminhibitor/em effects on the life prognosis ..." | ||
| Vol 4, No 1 (2008) | EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL” | Abstract similar documents |
| статья Редакционная | ||
| Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
| "... A role of angiotensin-converting enzyme (emACE/em) eminhibitors/em in cardiovascular diseases treatment ..." | ||
| Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... Data of studies devoted to application of angiotensin converting enzyme (emACE/em) eminhibitors/em in acute ..." | ||
| Vol 17, No 1 (2021) | A Clinical Case: the Risk Factors of Acute Kidney Injury in a Cardiological Patient | Abstract similar documents |
| E. A. Son, M. R. Kondratyuk, E. V. Fominykh, V. V. Fomin | ||
| "... common clinical conditions such as hypertension, multifocal ematherosclerosis/em with the development of renal ..." | ||
| Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
| M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
| "... converting enzyme eminhibitors/em (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..." | ||
| Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... The recent discussion about the dangers of using angiotensin-converting-enzyme (emACE/em) eminhibitors/em ..." | ||
| Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... enzyme eminhibitor/em (iACE) ramipril improves the prognosis in high risk cardio-vascular patients ..." | ||
| Vol 7, No 5 (2011) | СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... situation with arterial hypertension. emACE/em eminhibitors/em have a special place among the antihypertensive drugs ..." | ||
| Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
| O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
| "... Aim. To evaluate influence of the combined therapy with emACE/em eminhibitor/em (perindopril), diuretic ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (emACE/em) eminhibitors/em keep important ..." | ||
| Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
| "... Aim. To estimate an effect of enalapril, angiotensin converting enzyme (emACE/em) eminhibitor/em , on left ..." | ||
| Vol 20, No 2 (2024) | Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry | Abstract similar documents |
| V. S. Arakelyan, A. D. Erlikh, N. Sh. Amirov, E. Dubar, K. Vogtlaender, S. Debus | ||
| "... in the registry was ASA monotherapy (81.3%); emACE/em eminhibitors/em/ARBs were prescribed in 61.8%, lipid-l owering therapy ..." | ||
| Vol 6, No 2 (2010) | RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... Influence of the combined antihypertensive therapy, including combination of emACE/em eminhibitors/em ..." | ||
| Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
| A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
| "... for the combination of an emACE/em eminhibitor/em with a dihydropyridine calcium channel blocker are reviewed. Data from ..." | ||
| Vol 6, No 5 (2010) | NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya | ||
| "... are presented. The advantages of emACE/em eminhibitor/em+calcium channel blocker combination are shown in terms ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, emACE/em eminhibitors/em, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... Aim. To compare the results of 3-year follow-up of patients with peripheral ematherosclerosis/em (PA ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... 2 (D2) and chronic heart failure (CHF) treated with angiotensin converting enzyme (emACE/em) eminhibitors/em ..." | ||
| Vol 16, No 2 (2020) | LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period | Abstract similar documents |
| S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh | ||
| "... of use of acetylsalicylic acid, clopidogrel, statins, beta-blockers, emACE/em eminhibitors/em, angiotensin II ..." | ||
| Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
| O. V. Andropova, V. N. Anokhin | ||
| Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
| "... complex compared to routine therapy in patients with diabetes type 2 and emACE/em eminhibitor/em intolerance within ..." | ||
| Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... of cardiovascular complications (antiplatelets, β-blockers, emACE/em eminhibitors/em, statins) were not often prescribed ..." | ||
| Vol 4, No 5 (2008) | EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS | Abstract similar documents |
| S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya | ||
| "... Aim. To study adjuvant effect of betahistine dihydrochloride to emACE/em eminhibitors/em in patients ..." | ||
| Vol 8, No 6 (2012) | THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS | Abstract similar documents |
| S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina | ||
| "... -blockers, emACE/em eminhibitors/em, statins), at that emACE/em eminhibitors/em were prescribed more often than the others. Use ..." | ||
| Vol 6, No 4 (2010) | LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... that block RAAS were emACE/em eminhibitors/em. Lisinopril deserves special attention among the emACE/em eminhibitors/em ..." | ||
| Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. O. Shevchenko, O. P. Shevchenko | ||
| "... and hydrochlorothiazide are discussed. Reasonability of emACE/em eminhibitor/em and thiazide diuretic combination is supported due ..." | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| "... channel blockers, emACE/em eminhibitors/em) is evaluated. Special considerations of beta-blockers use ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... ,4%) patients received emACE/em eminhibitors/em, 435 (55%) patients - beta-blockers, 230 (29,1%) patients - calcium ..." | ||
| Vol 20, No 5 (2024) | Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova | ||
| "... -converting enzyme type 1 gene (emACE/em1), rs5186 of angiotensin II type 1 receptor gene (ATP1), and rs1403543 ..." | ||
| Vol 16, No 6 (2020) | Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery | Abstract similar documents |
| M. D. Nigmatkulova, E. B. Kleymenova, L. P. Yashina, V. A. Otdelenov, S. A. Payushchik, O. D. Konova, D. A. Sychev | ||
| "... CoA reductase eminhibitors/em and angiotensin-converting-enzyme (emACE/em) eminhibitors/em/ angiotensin receptor ..." | ||
| Vol 8, No 5 (2012) | THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE | Abstract similar documents |
| S. Y. Marcevich, M. L. Ginzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. Y. Drozdova, E. V. Danijel's, A. V. Fokina | ||
| "... -blockers, 35.3% — emACE/em eminhibitors/em, 15.7% — antiplatelet drugs, 1.9% — statins. Reduction in the hospital ..." | ||
| Vol 14, No 1 (2018) | COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman | ||
| "... .05) increased. In 2014-2015 the frequency of the prescriptions of emACE/em eminhibitors/em decreased (77.8 vs 86.5%; p0 ..." | ||
| Vol 7, No 5 (2011) | THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman | ||
| "... . Complex therapy (acetylsalicylic acid (ASA), beta-blockers (BB), emACE/em eminhibitors/em, statins) was prescribed ..." | ||
| Vol 7, No 1 (2011) | NEW ANTIPLATELET DRUGS (PART 1) | Abstract similar documents |
| A. B. Sumarokov | ||
| "... Antiplatelet agents are a necessary component of modern ematherosclerosis/em therapy. The difficulties ..." | ||
| Vol 7, No 5 (2011) | NEW ANTIPLATELET DRUGS. PART 2 | Abstract similar documents |
| A. B. Sumarokov | ||
| "... Antiplatelet agents are a necessary component of modern therapy of ematherosclerosis/em ..." | ||
| Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... pathogenic mechanisms of hypertension. The combination of an emACE/em eminhibitor/em and a dihydropyridine calcium ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... and long-lasting action. Lercanidipine had shown both in monotherapy and in combination with emACE/em eminhibitors/em ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... supplying beneficiaries. Diuretics, as well as some emACE/em eminhibitors/em, are not available in a number ..." | ||
| Vol 5, No 6 (2009) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina | ||
| "... of emACE/em eminhibitor/em and diuretic was performed each 2 weeks. Results. The significant antihypertensive ..." | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... Aim. To study the effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) eminhibitor/em ..." | ||
| Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... -Converting Enzyme emInhibitors/em and Angiotensin Receptor Blockers in Patients Without Heart Failure ..." | ||
| Vol 14, No 5 (2018) | Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case | Abstract similar documents |
| M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov | ||
| "... with P2Y12 eminhibitor/em was clinically manifested by repeated thrombotic events and was confirmed ..." | ||
| Vol 14, No 3 (2018) | COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU | Abstract similar documents |
| S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca | ||
| "... .6%, respectively). Conclusion. emACE/em eminhibitors/em, diuretics, BAB were priority classes in the prescribing ..." | ||
| Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| K. A. Gyamdzhyan, M. L. Maksimov | ||
| "... , angiotensin converting enzyme eminhibitors/em and sartans, are compared. Data from evidence base of the both drug ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... .23. Patients were randomized into 4 treatment groups: Group A1 (angiotensin converting enzyme (emACE/em) eminhibitors/em ..." | ||
| Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
| G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
| "... . Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme emInhibitors/em ..." | ||
| Vol 1, No 1 (2005) | EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE | Abstract similar documents |
| Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen | ||
| "... Expert consensus document on angiotensin converting enzyme eminhibitors/em in cardiovascular disease. ..." | ||
| Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
| E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
| "... Aim. To pursue pharmacoeconomic analysis of two drug combinations of emACE/em eminhibitor/em (enalapril ..." | ||
| Vol 9, No 5 (2013) | PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| O. A. Shtegman | ||
| "... received target doses of emACE/em eminhibitors/em/sartans and beta-blockers, respectively. Majority of CHF ..." | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| "... amlodipine 5-10 mg daily in addition to standard therapy (emACE/em eminhibitors/em, beta-blockers, aspirin, statins ..." | ||
| Vol 2, No 1 (2006) | THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov | ||
| "... Aim. To assess an influence of emACE/em eminhibitor/em enalapril on daily profile of blood pressure (BP ..." | ||
| Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
| "... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (ematherosclerosis/em ..." | ||
| Vol 5, No 2 (2009) | EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| G. F. Andreeva, A. D. Deev, V. M. Gorbunov | ||
| "... not affect QoL. emACE/em eminhibitors/em similarly improved QoL. Conclusion. Antihypertensive drugs (diltiazem ..." | ||
| Vol 15, No 4 (2019) | The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients | Abstract similar documents |
| M. P. Savenkov, S. N. Ivanov, M. P. Mikhaylusova, M. V. Borschevskaya, A. M. Savenkova, N. Y. Kozachenko, E. S. Sherifova | ||
| "... of treatment. Conclusion. The fixed dose combination of the emACE/em eminhibitor/em lisinopril (5, 10 or 20 mg ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... converting enzyme (emACE/em) eminhibitors/em (p=0.040) and statins (p=0.001). Moreover, in young patients with MI ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... considers the place of proprotein convertase subtilisin/kexin type 9 (PCSK9) eminhibitors/em in the prevention ..." | ||
| Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
| "... are of great practical interest, as associative effect of angiotensin-converting enzyme eminhibitors/em ..." | ||
| Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
| "... was 26.1%. We have noted insufficient emACE/em eminhibitors/em/angiotensin receptor blockers (ARB) and beta ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... as a drug of choice from the P2Y12 eminhibitor/em group, the use of low doses of acetylsalicylic acid (ASA ..." | ||
| Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
| V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
| "... of the combination of thiazide-like diuretic with calcium channel blocker in the morning and emACE/em eminhibitor/em in bedtime ..." | ||
| Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
| "... ингибитора ангиотензинпревращающего фермента (emиАПФ/em) эналаприла (Энам, Dr.Reddy’s). Материал и методы ..." | ||
| Vol 19, No 5 (2023) | Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes | Abstract similar documents |
| A. M. Kochergina, O. L. Barbarash | ||
| "... %, respectively. All study participants were discontinued from a previously prescribed ARBs or emACE/em eminhibitors/em ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... .01, respectively). Patients treated with emACE/em eminhibitors/em or angiotensin receptor blockers (ARB) had lower all-cause ..." | ||
| Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
| M. Loukianov | ||
| "... was 26.1%. We have noted insufficient emACE/em eminhibitors/em/angiotensin receptor blockers (ARB) and beta ..." | ||
| Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
| O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
| "... (in different regions). Patients received emACE/em eminhibitors/em in 50-54% of cases, angiotensin receptor blockers ..." | ||
| Vol 6, No 1 (2010) | EVOLUTION STAGES OF LOW RENIN HYPERTENSION | Abstract similar documents |
| S. V. Akhadov, G. R. Ruzbanova, G. S. Molchanovа | ||
| "... and the high cardiovascular risk were included into the study. All patients received emACE/em eminhibitor/em, enalapril ..." | ||
| Vol 9, No 2 (2013) | LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATION | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. Yu. Martsevich, M. L. Ginzburg, N. P. Kutishenko, L. Yu. Drozdova, A. V. Akimova, A. Yu. Suvorov, M. M. Loukianov, N. A. Dmitrieva, O. V. Lerman, N. Yu. Zhuravskaya, E. V. Daniels, A. V. Fokina, V. N. Yudaev, V. P. Smirnov, A. M. Kalinina, S. V. Kotov, L. V. Stahovskaya | ||
| "... }9.6 years old). 374 (75%) patients were prescribed emACE/em eminhibitors/em, 421 (85%) - antiplatelet agents ..." | ||
| Vol 4, No 1 (2008) | COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL) | Abstract similar documents |
| N. M. Chihladze, O. A. Sivakova, H. F. Samedova, G. N. Litonova, E. B. Yarovaya, I. E. Chazova | ||
| "... Aim. To compare antihypertensive efficacy of АТ1 receptors blocker (losartan) and emACE/em eminhibitor/em ..." | ||
| Vol 4, No 2 (2008) | MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY | Abstract similar documents |
| L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak | ||
| "... failure (CHF). Material and methods. 30 patients with CHF taking standard therapy (diuretic, emACE/em ..." | ||
| 1 - 100 of 391 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
